GPT and metabolic dysfunction-associated steatotic liver disease: Moolla et al. prospectively followed NAFLD patients attending a dedicated, multidisciplinary metabolic hepatology clinic in Oxford, UK, finding considerable improvements in liver and cardiometabolic health with reductions in ALT, weight, HbA1c, total cholesterol, QRisk3 score, and liver stiffness measurements (65).